FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Date of Report (Date of earliest event reported): March 17, 2003 MEDTOX SCIENTIFIC, INC. Delaware 1-11394 95-3863205 (651) 636-7466 |
Item 5. Other Events On March 17, 2003, the Company announced final results for the fourth quarter and year-end December 31, 2002, as described in the press release attached as Exhibit 99.1. |
2 |
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
MEDTOX Scientific, Inc.
Date: March 17, 2003 By: /s/ Richard J. Braun
Name: Richard J. Braun
Title: Chief Executive Officer
3 |